WebBioAge Labs 7,131 followers on LinkedIn. We are mapping human aging to develop a pipeline of therapies to treat disease and extend healthy lifespan. BioAge is a platform-driven, clinical-stage ... WebApr 15, 2024 · Dray and his team have helped BioAge test BGE-105 in mouse models of muscle regeneration under a materials transfer agreement with Amgen ahead of the licensing deal. BioAge found the drug through its discovery platform, which uses human data to understand the molecular causes of aging—including proteins, metabolites and …
BioAge Labs CEO, Founder, Key Executive Team, Board of Directors ...
WebOct 4, 2024 · As the vice president of in-vivo biology at BioAge, Dr. Rebo leads the company’s internal in-vivo platform to find and assess the viability of new druggable targets for aging diseases and biomedical regeneration. With considerable business as well as academic experience in the aging field under his belt, Justin joined the BioAge team in … WebBioAge Labs Profile and History. BioAge is a clinical-stage biotechnology company developing a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging. The company uses its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking ... flvs us government 2.04
BioAge Andreessen Horowitz
WebNov 18, 2024 · Here are further demographic highlights of the leadership team: The BioAge executive team is 50% female and 50% male. 64% of the management team is White. 11% of BioAge management is Hispanic or Latino. 13% of the management team is Black or African American. WebOct 13, 2024 · BioAge Labs, Inc. (“BioAge”), a privately held clinical-stage biotechnology company developing therapeutics that target the molecular causes of aging ... and our … WebWe appreciate your interest in joining the BIOAGE team and in promoting bio-algae concentrates! We welcome new practitioners and other resellers and will do everything … green hills chowchilla real estate